Know what this Phoenix hip guide is for

Use the guide for practical questions

The pages explain common sources of hip soreness, home steps, and warning signs. They also tell you what may happen during an exam.

General health information can't diagnose the tissue causing your soreness. Your symptoms, health history, and exam are needed for that.

The guide keeps joint soreness separate from outer-tendon soreness because the body treats those tissues differently. This helps you ask why a choice fits your hip.

It also avoids promising more relief than the facts support. Human results matter for human care, and animal findings alone can't predict how you will feel.

Know who runs the guide

The owners of the QC Kinetix clinics serving greater Phoenix operate this publication and may benefit when a reader schedules there. That is why the ownership statement also appears at the bottom of the site.

The medical pages still tell you when emergency care or a surgery opinion may make more sense. They don't replace advice from your own doctor or nurse.

Use the guide to note when soreness began, what worsens it, and which tasks have become hard. Bring those notes and your medicine list to the exam.

Keep your own doctor informed when your symptoms or medicines change. That keeps general reading tied to the care you already receive.

Ask what the staff found, what each choice involves, and what remains uncertain. QC Kinetix provides consultations and regenerative treatments, meaning non-surgical clinic choices discussed after licensed staff examine you.

Sources

1. The AAOS 2024 clinical practice guideline summary for management of osteoarthritis of the hip is based on a systematic review of studies in adults 18 and older and contains eight recommendations and nine options; it also explicitly highlights gaps in the literature and areas needing future research.

   Hannon CP, et al. — American Academy of Orthopaedic Surgeons Clinical Practice Guideline Summary: Management of Osteoarthritis of the Hip.. Journal of the American Academy of Orthopaedic Surgeons, 2024. DOI: 10.5435/JAAOS-D-24-00420.

2. A Bayesian network meta-analysis of 11 randomized trials (1353 patients) in hip osteoarthritis found that at 2-4 months and 6 months NO injectable - corticosteroid, hyaluronic acid or platelet-rich plasma - significantly outperformed a saline placebo injection for pain or function. Pooled change from baseline exceeded the minimal clinically important difference in every arm including placebo.

   Gazendam A, et al. — Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials.. British Journal of Sports Medicine, 2021. DOI: 10.1136/bjsports-2020-102179.

3. FDA states verbatim that regenerative medicine products including stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly, amniotic fluid and exosomes have NOT been approved 'for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells derived from umbilical cord blood, approved only for disorders affecting blood production.

   U.S. Food and Drug Administration — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes.. FDA, 2026.